Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis.
Imagenebio stock last closed at $17.90, up 17.07% from the previous day, and has decreased 11.21% in one year. It has overperformed other stocks in the Biotechnology industry by 0.56 percentage points. Imagenebio stock is currently +53.67% from its 52-week low of $11.65, and -23.11% from its 52-week high of $23.28.
As of Jul 31, 2025, there are 4.02M shares of IMA outstanding. The market value of IMA is $71.98M. In the last 24 hours, 122,000 IMA shares were traded.
How to Buy Imagenebio Stock
Not sure how to invest in Imagenebio stock? Here's how.
Choose where to buy Imagenebio stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Imagenebio stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Fund your brokerage account: Choose your payment method and add your info.
Research Imagenebio stock: The Imagenebio ticker symbol is IMA. Is Imagenebio stock a good investment? Should you buy shares of IMA? How do IMA's underlying business fundamentals look? Do top analysts think Imagenebio is a good buy? Why has IMA's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if IMA is a good stock to buy).
Place your IMA buy order: Decide if you will purchase IMA shares at the current market price or use a limit order to purchase IMA stock at a given price.
Keep an eye on your investment in IMA: Create a watchlist to track your investment in Imagenebio shares.
Step 1: Choose where to buy Imagenebio stock
You will need an online brokerage account to access the NASDAQ market and buy IMA shares.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you are able to buy IMA today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Imagenebio stock
Once you have decided on the best place to buy Imagenebio stock, it's absolutely critical to research their stock before you buy, so you can understand the risk as well as the upside.
Imagenebio Metrics
IMA Price
$17.90
1w %
8.88%
1y %
-11.21%
5y %
N/A
P/E
-2.33x
P/B
0.62x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$30.74M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$71.98M
Next Earnings
Aug 7, 2025
Next Dividend
N/A
IMA Fundamentals
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on IMA's stock page.
Is IMA stock undervalued or overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge IMA's intrinsic value.
Using relative valuations ratios:
IMA may be undervalued based on its P/B ratio of 0.62x, relative to Biotechnology industry P/B ratio of 4.28x
Last year, IMA revenue was $0.00. Over the last four year, IMA's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 46.35%.
No, Imagenebio doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your IMA buy order
You have two main options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a specific dollar amount limit, use a limit order.
Click the Open Trade button and your broker will execute the order.
If you need more assistance buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Imagenebio share?
As of Jul 31, 2025, it costs $17.90 to buy one share of Imagenebio stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.447 shares of IMA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.